Streetbeat News

Regulatory

DOGEUSD

Crypto analyst Ali Martinez predicts a potential surge for Dogecoin in November, citing historical patterns and technical formations. Dogecoin is currently trading at $0.161, with a key resistance level at $0.20. The crypto market is optimistic about favorable regulatory changes post-U.S. elections.

Portfolio Pulse from Rounak Jain

November 02, 2024 | 5:42 am

TSLA

Tesla may eventually adopt Lidar technology for autonomous driving, despite CEO Elon Musk's criticism of it as a 'crutch'. Ross Gerber, CEO of Gerber Kawasaki, believes Tesla will need Lidar to achieve full autonomy. Currently, Tesla relies on cameras and AI, but other companies like Waymo use Lidar. Tesla plans to start an autonomous ride-hail service next year, with a new robotaxi product, the Cybercab, expected by 2027.

Portfolio Pulse from Anan Ashraf

November 02, 2024 | 4:37 am

APXI

APX Acquisition Corp. I (NASDAQ: APXI) has received a delisting notification from Nasdaq for its warrants and units due to non-compliance with market value requirements. The company does not plan to appeal, and the delisting will proceed, affecting only the warrants and units, not the Class A shares.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:55 pm

SPY

STLA

Donald J. Trump, the Republican nominee, has announced a plan to impose a 100% tariff on every car if Stellantis moves its operations. This statement could impact Stellantis' stock and the broader market.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:51 pm

GRYP

Gryphon Digital Mining and Unit have notified Coinmint of their decision not to renew the Colocation Mining Services Agreement, which was initially signed on July 1, 2021. This information was disclosed in an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:51 pm

LIVN

LivaNova announced that the Centers for Medicare & Medicaid Services (CMS) will maintain VNS Therapy for drug-resistant epilepsy (DRE) at Level 5 Ambulatory Payment Classification (APC) under the 2025 Medicare Hospital Outpatient Prospective Payment System. LivaNova will continue to seek reimbursement opportunities for this therapy.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 10:48 pm

ITRM

PFE

Iterum Therapeutics has notified Pfizer of its decision to defer a milestone payment related to ORLYNVAH for two years, until October 25, 2026, as per an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 9:25 pm

MDT

CMS has granted a Transitional Pass-Through Payment for Medtronic's Symplicity Spyral Renal Denervation Catheter, effective for up to three years starting January 1, 2025. This aims to enhance patient access to innovative technology.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 9:24 pm

CERO

CERo Therapeutics has received a delisting notice from Nasdaq due to non-compliance with the MVLS requirement. The company has requested a hearing to appeal the decision and plans to present a compliance plan. The outcome of the appeal is uncertain.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 9:11 pm

ADAP

Adaptimmune Therapeutics has received a notice from Nasdaq for non-compliance with the minimum bid price requirement. This could lead to potential delisting if the issue is not resolved.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 9:07 pm